Skip to main content
. 2022 Jul 22;12:926352. doi: 10.3389/fcimb.2022.926352

Figure 3.

Figure 3

TF-bearing platelet-derived EVs correlates with poor outcome in COVID-19 patients. The percentage of total circulating (A) and platelet derived EVs (B) of COVID-19 survivors and non-survivors. The concentration of TF-bearing platelet-derived EVs (C) and the percentage of platelet-derived EVs expressing TF (D) are shown for covid survivors and non-survivors. Medians with interquartile range are shown. Individual values for COVID-19 survivors (green dots), and COVID-19 non-survivors (red dots) are shown. The blue line and shade indicate the median and interquartile range of the healthy donor. *p<0.05 and **p<0.001.